Acetaminophen toxicity: Changing perceptions on a social/medical issue

Hepatology

Volumn 46, Issue 4, 2007, Pages 966-970

  Lee, William M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NARCOTIC AGENT; NON PRESCRIPTION DRUG; NYQUIL; PARACETAMOL; UNCLASSIFIED DRUG;

ALCOHOL ABUSE; DRUG APPROVAL; DRUG INTOXICATION; DRUG LABELING; DRUG MARKETING; DRUG PACKAGING; HEALTH CARE POLICY; HEALTH HAZARD; HOSPITALIZATION; HUMAN; LIVER FAILURE; PERCEPTION; PRESCRIPTION; PRIORITY JOURNAL; REVIEW;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; DRUG AND NARCOTIC CONTROL; DRUG INDUSTRY; DRUG LABELING; HUMANS; LIVER FAILURE, ACUTE; PAIN; PUBLIC POLICY; RISK FACTORS; SOCIAL PERCEPTION; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 36349004846     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21926     Document Type: Review

References (23)

1. Ostapowicz GA, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SBH, Lee WM, and the Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:945-54.
2. Proceedings of the FDA NDAC meeting September 19, 2002. Testimony of Parivash Nourjah, PhD. www.fda.gov/ohrms/dockets/ac/cder02. htm#NonprescriptionDrugs Lee WM. Acute liver failure in the United States. Semin Liv Dis 2003, 23:217-26.
3. Top 200 Generic Drugs By Units in 2006. Available at: http://www.drugtopics.com/drugtopics/data/articlestandard/drugtopics/092007/ 407652/article.pdf.
4. Thompson JS, Prescott LF. Liver damage and impaired glucose tolerance after paracetamol overdose. Br Med J 1966;2:506-07.
5. Boyer TD, Rouff SL. Acetaminophen-induced hepatic necrosis and renal failure. JAMA 1971;218:440-441.
6. Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 2005;4:489-99.
7. Zimmerman HJ, Maddrey WC. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. HEPATOLOGY 1995;22:767-773.
8. Wootton FT, Lee WM. Acetaminophen hepatotoxicity in the alcoholic. Southern Med J 1990;83:1047-1049.
9. Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994;272:1845-1850.
10. Makin AJ, Williams R. Acetaminophen-induced hepatotoxicity: predisposing factors and treatments. Adv Intern Med 1997;42:453-483.
11. Larson AM, Fontana RJ, Davern TJ, Polson J, Lalani EK, Hynan LS, et al. Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. HEPATOLOGY 2005:42:1367-1372.
12. Schiodt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997;337:1112-1117.
13. Shayiq RM, Roberts DW, Rothstein K, Snawder JE, Benson W, Ma X, et al. Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury. HEPATOLOGY 1999;29:451-463.
14. Testimony of Dr. Sarah Erush from University of Pennsylvania at NDAC heating, September 19, 2002, complete transcript at: http://www.fda.gov/ohrms/ dockets/ac/02/transcripts/3882T1.htm.
15. Department of Health and Human Services, Food and Drug Administration 21 CFR Parts 201 and 343 [Docket No. 1977N-0094L] RIN 0910-AF36 Internal Analgesic, Antipyretic, and Anti-rheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph; Required Warnings and Other Labeling. Available at: http://www.accessdata.fda.gov/scripts/oc/ohrms/ frbydocket.cfm.
16. Hawton K, Ware C, Mistry H, Hewitt J, Kingsbury S, Roberts D, et al. Why patients choose paracetamol for self poisoning and their knowledge of its dangers. BMJ 1995;310:164.
17. Makin A, Wendon J, Williams R. A seven year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology 1995;109:1907-1916.
18. Wilkinson S, Taylor G, Templeton L, Mistral W, Salter E, Bennett P. Admissions to Hospital for deliberate self-harm in England 1995-2000: an analysis of Hospital Episode Statistics. J Public Health Med 2002;24:179-183.
19. Hawton K, Simkin S, Deeks J, Cooper J, Johnston A, Waters K, et al. UK Legislation on analgesic packs: before and after study of long term effect on poisonings. BMJ 2004;329:1076-1081.
20. Hughes B, Durran A, Langford N, Mutimer D. Paracetamol Poisoning - impact of pack size restrictions. J Clin Pharm Ther 2003;28:307-310.
21. Greene S, Dargan P, Leman P, Jones A. Paracetamol availability and recent changes in paracetamol poisoning: is the 1998 legislation limiting availability of paracetamol being followed? Postgrad Med J 2006;82:520-523.
22. Rezende G, Roque-Alfonso AM, Samuel D, Gigou M, Nicand E, Ferre V, et al. Viral and clinical factors associated with the fulminant course of hepatitis A infection. HEPATOLOGY 2004;38:613-618.
23. Poison J, Ocama P, Larson AM, Hynan L, Lalani E, Harrison M, et al. Role of acetaminophen in acute liver failure due to viral hepatitis [Abstract]. HEPATOLOGY 2003;38(Suppl):544A.